Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

White T-shirts get a lot of attention, but let’s not forget their equally versatile counterpart: the exceedingly wearable, deceptively simple black T-shirt. It’s a staple you can wear to work ...

Image: Was the right decision made not to send off David Brooks [left] after his clash with Marc Cucurella at Stamford Bridge on Tuesday? Ex-top flight referee Dermot Gallagher assesses the ...

Semaglutide works by mimicking a hormone (GLP-1) that regulates appetite and blood sugar. Once you stop taking it, your body needs time to adjust. You might experience: Before stopping semaglutide ...

T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...

The glucagon-like peptide-1 receptor (GLP-1R) market experienced significant growth in 2023, generating $37.2 billion in sales, with Denmark’s Novo Nordisk (NOV: N) and US major Eli Lilly (NYSE: LLY) ...

This product introduction aligns with a growing consumer trend that emphasises high-protein foods, particularly among those following GLP-1 dietary guidelines. The Max Pro line aims to cater to ...

Those who received GLP-1s experienced decreased absolute and relative weight loss vs. placebo across 26 randomized studies. Retatrutide conferred the greatest weight reduction among all GLP-1s.